Learn More
Abcam Canertinib (CI-1033), EGFR and HER2/ErbB2 tyrosine kinase inhibitor, 50MG
Supplier: Abcam AB14140250MG
MW 558.9 Da, Purity >99%. Potent, irreversible pan-ErbB tyrosine kinase inhibitor (IC₅₀ values are 1.5 and 9 nM at EGFR and ErbB2 respectively). Orally active. Antitumor and radiation-sensitizing agent. Active in vivo and in vitro.
The product is subject to the following: Abcam Restricted Use Statement
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.